Owners
History
2023: Thoma Bravo bought Nextgen Healthcare
On September 6, 2023, American private equity firm Thoma Bravo announced an agreement to buy NextGen Healthcare, a healthcare software provider. The transaction amount is $1.8 billion, including debt.
NextGen's technology platform helps healthcare providers perform operations ranging from digitizing patients' medical records to financial management. Thus, healthcare institutions can improve the efficiency of their activities and improve the quality of customer service.
Under the terms of the contract, NextGen shareholders will receive $23.95 for each security. This represents a premium of 46.4% to the stock value of the acquired company at the close of trading on August 22, 2023 - the last trading day before information about a possible transaction emerged. The transaction is planned to be carried out at the expense of funds.
The deal, unanimously approved by NextGen's board, is expected to conclude in the fourth calendar quarter of 2023, subject to normal closing conditions, including shareholder approval and required regulatory approvals. The merger is overseen by lawyers for Morgan Stanley & Co. LLC, Latham & Watkins LLP, William Blair & Company и Goodwin Procter LLP. Upon completion of the transaction, NextGen's common stock will no longer be listed on any public stock exchange.
 | Thoma Bravo has more than 20 years of experience investing in leading software and IT technology companies. We look forward to joining forces to fulfill our mission to improve the health care field, "said David Sides, President and CEO of NextGen.[1] |  |
Notes
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |